154 related articles for article (PubMed ID: 19195736)
1. MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.
Khodadadian M; Leroux ME; Auzenne E; Ghosh SC; Farquhar D; Evans R; Spohn W; Zou Y; Klostergaard J
Lung Cancer; 2009 Oct; 66(1):48-57. PubMed ID: 19195736
[TBL] [Abstract][Full Text] [Related]
2. Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells.
Wang J; Liu X; Jiang W
Chin Med J (Engl); 2000 Oct; 113(10):957-60. PubMed ID: 11775848
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer.
Gu T; Ohashi R; Cui R; Tajima K; Yoshioka M; Iwakami S; Sasaki S; Shinohara A; Matsukawa T; Kobayashi J; Inaba Y; Takahashi K
Lung Cancer; 2009 Nov; 66(2):176-83. PubMed ID: 19285749
[TBL] [Abstract][Full Text] [Related]
4. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
Guo L; Zhou Y; Sun Y; Zhang F
Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of Bax in ceramide-resistant HL-60 subline.
Sawai H; Kawai S; Domae N
Biochem Biophys Res Commun; 2004 Jun; 319(1):46-9. PubMed ID: 15158440
[TBL] [Abstract][Full Text] [Related]
6. Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.
Nagata J; Kijima H; Hatanaka H; Asai S; Miyachi H; Abe Y; Yamazaki H; Nakamura M; Watanabe N; Mine T; Kondo T; Scanlon KJ; Ueyama Y
Int J Oncol; 2002 Nov; 21(5):1021-6. PubMed ID: 12370750
[TBL] [Abstract][Full Text] [Related]
7. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines.
Slovak ML; Ho JP; Bhardwaj G; Kurz EU; Deeley RG; Cole SP
Cancer Res; 1993 Jul; 53(14):3221-5. PubMed ID: 8391919
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.
Leroux ME; Auzenne E; Evans R; Hail N; Spohn W; Ghosh SC; Farquhar D; McDonnell T; Klostergaard J
Prostate; 2007 Nov; 67(15):1699-717. PubMed ID: 17879964
[TBL] [Abstract][Full Text] [Related]
9. [Involvement of bcl-2 in multidrug resistance in human small cell lung cancer cell subline H446/DDP].
Ji FY; Qian GS; Qian P; Chen Y; Guo RL; Li SP; Huang GJ
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar; 29(3):156-60. PubMed ID: 16677475
[TBL] [Abstract][Full Text] [Related]
10. New advances in the second-line treatment of small cell lung cancer.
Hurwitz JL; McCoy F; Scullin P; Fennell DA
Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
[TBL] [Abstract][Full Text] [Related]
11. Cellular models of drug- and radiation-resistant small cell lung cancer.
Davey RA; Locke VL; Henness S; Harvie RM; Davey MW
Anticancer Res; 2004; 24(2A):465-71. PubMed ID: 15152945
[TBL] [Abstract][Full Text] [Related]
12. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
Doyle LA; Ross DD; Ordonez JV; Yang W; Gao Y; Tong Y; Belani CP; Gutheil JC
Br J Cancer; 1995 Sep; 72(3):535-42. PubMed ID: 7669558
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression.
Bektas M; Jolly PS; Müller C; Eberle J; Spiegel S; Geilen CC
Oncogene; 2005 Jan; 24(1):178-87. PubMed ID: 15637591
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of multidrug resistance of human small cell lung cancer cell line H446/VP.
Wang YL; Yan YL; Zhou NJ; Han S; Zhao JX; Cao CL; Lü YH
Chin Med J (Engl); 2010 Nov; 123(22):3299-303. PubMed ID: 21163134
[TBL] [Abstract][Full Text] [Related]
15. A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene.
Narasaki F; Oka M; Fukuda M; Nakano R; Ikeda K; Takatani H; Terashi K; Soda H; Yano O; Nakamura T; Doyle LA; Tsuruo T; Kohno S
Cancer Chemother Pharmacol; 1997; 40(5):425-32. PubMed ID: 9272120
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
Stordal BK; Davey MW; Davey RA
Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
[TBL] [Abstract][Full Text] [Related]
18. [Expression and reversion of drug resistance- and apoptosis-related genes of a DDP-resistant lung adenocarcinoma cell line A549DDP].
Wang J; Liu X; Wu M
Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):422-6. PubMed ID: 11776616
[TBL] [Abstract][Full Text] [Related]
19. Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells.
Noguchi M; Kabayama K; Uemura S; Kang BW; Saito M; Igarashi Y; Inokuchi J
Glycobiology; 2006 Jul; 16(7):641-50. PubMed ID: 16571667
[TBL] [Abstract][Full Text] [Related]
20. Relationship between chemotherapy response of small cell lung cancer and P-glycoprotein or multidrug resistance-related protein expression.
Hsia TC; Lin CC; Wang JJ; Ho ST; Kao A
Lung; 2002; 180(3):173-9. PubMed ID: 12177731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
